A drug used to treat rheumatoid arthritis.
| Member | Definition | Class |
|---|
| 2-hydroxyacetanilide | A member of the class of phenols that is 2-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group. A positional isomer of paracetamol which possesses anti-inflammatory, anti-arthritic and anti-platelet aggregation properties. | 2-acetamidophenol; 2'-Hydroxyacetanilide |
| acetovanillone | An aromatic ketone that is 1-phenylethanone substituted by a hydroxy group at position 4 and a methoxy group at position 3. | apocynin |
| alminoprofen | A substituted aniline that is ibuprofen in which the isobutyl group is replaced by a (2-methylprop-2-en-1-yl)amino group. A non-steroidal anti-inflammatory drug, it is used for treatment of inflammatory and rheumatic disorders. | alminoprofen |
| alvocidib | A synthetic dihydroxyflavone that is 5,7-dihydroxyflavone which is substituted by a 3-hydroxy-1-methylpiperidin-4-yl group at position 8 and by a chlorine at the 2' position (the (-)-3S,4R stereoisomer). A cyclin-dependent kinase 9 (CDK9) inhibitor, it has been studied for the treatment of acute myeloid leukaemia, arthritis and atherosclerotic plaque formation. | alvocidib |
| aminopropionitrile | An aminopropionitrile carrying an amino group at the beta-position. | beta-aminopropionitrile |
| ampiroxicam | A benzothiazine that is the 1-[(ethoxycarbonyl)oxy]ethyl ether of piroxicam. A prodrug for piroxicam, it is used for the relief of pain and inflammation in musculoskeletal disorders such as rheumatoid arthritis and osteoarthritis. | ampiroxicam |
| ampyrone | A pyrazolone, a member of the class of pyrazoles that is antipyrine substituted at C-4 by an amino group. It is a metabolite of aminopyrine and of metamizole. | 4-aminoantipyrine |
| as 605240 | A quinoxaline derivative that is quinoxaline in which the hydrogen at position 6 is replaced by a (2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl group. It is a potent inhibitor of the PI3Kgamma, with an IC50 of 8 nM and inhibits the progression of joint inflammation and damage in both lymphocyte-independent and dependent mouse models of rheumatoid arthritis. | (5Z)-5-(quinoxalin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione |
| baricitinib | A pyrrolopyrimidine that is 7H-pyrrolo[2,3-d]pyrimidine substituted by a 1-[3-(cyanomethyl)-1-(ethanesulfonyl)azetidin-3-yl]-1H-pyrazol-4-yl group at position 5. It is an FDA approved selective Janus Kinase 1 and 2 (JAK1 and JAK2) inhibitor used for the treatment of rheumatoid arthritis. | baricitinib |
| beta-aminopropionitrile fumarate (2:1) | A fumarate salt prepared from beta-aminopropionitrile by reaction of one molecule of fumaric acid for every two molecules of beta-aminopropionitrile. | beta-aminopropionitrile hemifumarate |
| cenicriviroc | A member of the class of benzazocines that is (5Z)-1,2,3,4-tetrahydro-1-benzazocine which is substituted by a 2-methylpropyl, N-{4-[(S)-(1-propyl-1H-imidazol-5-yl)methanesulfinyl]phenyl}carboxamide and 4-(2-butoxyethoxy)phenyl groups at positions 1, 5 and 8, respectively. It is a potent chemokine 2 and 5 receptor antagonist currently in development for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis (NASH). | cenicriviroc |
| chloroquine | An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis. | chloroquine |
| cyclosporine | A cyclic nonribosomal peptide of eleven amino acids; an immunosuppressant drug widely used in post-allogeneic organ transplant to reduce the activity of the patient's immune system, and therefore the risk of organ rejection. Also causes reversible inhibition of immunocompetent lymphocytes in the G0- and G1-phase of the cell cycle. | cyclosporin A |
| dipyrone | A pyrazole that is antiipyrine substituted at C-4 by a methyl(sulfomethyl)amino group, the sodium salt of which, metamizole sodium, was widely used as a powerful analgesic and antipyretic, but withdrawn from many markets from the 1970s due to a risk of causing risk of causing agranulocytosis. | metamizole |
| dipyrone | An organic sodium salt of antipyrine substituted at C-4 by a methyl(sulfonatomethyl)amino group, commonly used as a powerful analgesic and antipyretic. | metamizole sodium |
| flunoxaprofen | A monocarboxylic acid that is propionic acid substituted at position 2 by a 2-(4-chlorophenyl)-1,3-benzoxazol-5-yl group (the S-enantiomer). Although it was shown to be effective in treatment of rheumatoid arthritis and osteoarthritis, the clinical use of flunoxaprofen was discontinued due to possible hepatotoxic side-effects. | flunoxaprofen |
| hmr 1275 | A hydrochloride salt resulting from the formal reaction of equimolar amounts of alvocidib and hydrogen chloride. A cyclin-dependent kinase 9 (CDK9) inhibitor, it has been studied for the treatment of acute myeloid leukaemia, arthritis and atherosclerotic plaque formation. | alvocidib hydrochloride |
| hydroxychloroquine | An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions. | hydroxychloroquine |
| isoxicam | A monocarboxylic acid amide that is piroxicam in which the pyrid-2-yl group is replaced by a 5-methyl-1,2-oxazol-3-yl group. A non-steroidal anti-inflammatory drug, it was withdrawn from the market in the 1980s following its association with cases of Stevens-Johnson syndrome. | isoxicam |
| levamisole | A 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole that has S configuration. It is used (generally as the monohydrochloride salt) to treat parasitic worm infections in pigs, sheep and cattle and was formerly used in humans as an adjuvant to chemotherapy for the treatment of various cancers. It is also widely used as an adulterant to coccaine. | levamisole |
| madecassoside | A triterpenoid saponin that is a trisaccharide derivative of madecassic acid. Isolated from Centella asiatica, it exhibits anti-inflammatory, antioxidant and antirheumatic activities. | madecassoside |
| masitinib | A member of the class of benzamides that is the carboxamide resulting from the formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary amino group of 4-methyl-N(3)-[4-(pyridin-3-yl)-1,3-thiazol-2-yl]benzene-1,3-diamine. It is a highly selective oral tyrosine kinase inhibitor. | masitinib |
| meclofenamate sodium anhydrous | A hydrate that is the monohydrate of the sodium salt of meclofenamic acid. It is used for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis. | sodium meclofenamate monohydrate |
| meclofenamic acid | An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis. | meclofenamic acid |
| mefenamic acid | An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis. | mefenamic acid |
| methotrexate | | methotrexate |
| mobic | A benzothiazine that is piroxicam in which the pyridin-2-yl group is replaced by a 5-methyl-1,3-thiazol-2-yl group. A non-steroidal anti-inflammatory drug and selective inhibitor of COX-2, it is used particularly for the management of rheumatoid arthritis. | meloxicam |
| pamapimod | A member of the class of pyridopyrimidines that is 8-methylpyrido[2,3-d]pyrimidin-7(8H)-one carrying additional (1,5-dihydroxypentan-3-yl)amino and 2,4-difluorophenoxy substituents at positions 2 and 6 respectively. It is a potent inhibitor of MAPK and is used for treatment of rheumatoid arthritis. | pamapimod |
| penicillamine | An optically active form of penicillamine having D-configuration. Pharmaceutical form (L-form is toxic) of chelating agent used to treat heavy metal poisoning. | D-penicillamine |
| phenylbutazone | A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position. | phenylbutazone |
| piroxicam | A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide with the exocyclic nitrogen of 2-aminopyridine. A non-steroidal anti-inflammatory drug of the oxicam class, it is used to relieve pain and works by preventing the production of endogenous prostaglandins involved in the mediation of pain, stiffness, tenderness and swelling. | piroxicam |
| propionylcarnitine | An O-acylcarnitine compound having propanoyl as the acyl substituent. | O-propanoylcarnitine |
| salicylamide | The simplest member of the class of salicylamides derived from salicylic acid. | salicylamide |
| salicylsalicylic acid | A dimeric benzoate ester obtained by intermolecular condensation between the carboxy of one molecule of salicylic acid with the phenol group of a second. It is a prodrug for salycylic acid that is used for treatment of rheumatoid arthritis and osteoarthritis and also shows activity against type II diabetes. | salsalate |
| suprofen | An aromatic ketone that is thiophene substituted at C-2 by a 4-(1-carboxyethyl)benzoyl group. | suprofen |
| suxibuzone | A pyrazolidine that is phenylbutazone which is substituted by a 3-carboxypropanoylmethyl group at the 4-position. Suxibuzone is a prodrug for phenylbutazone and is commonly used as an anti-inflammatory drug in horses. | suxibuzone |
| tofacitinib | A pyrrolopyrimidine that is pyrrolo[2,3-d]pyrimidine substituted at position 4 by an N-methyl,N-(1-cyanoacetyl-4-methylpiperidin-3-yl)amino moiety. Used as its citrate salt to treat moderately to severely active rheumatoid arthritis. | tofacitinib |
| valdecoxib | A member of the class of isoxazoles that is isoxazole which is substituted at positions 3, 4 and 5 by phenyl, p-sulfamoylphenyl and methyl groups, respectively. A selective cyclooxygenase 2-inhibitor, it used as a nonsteroidal anti-inflammatory drug (NSAID) for the treatment of arthritis from 2001 until 2005, when it was withdrawn following concerns of an associated increased risk of heart attack and stroke. | valdecoxib |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 27.1044 | 1 | 8 |
| 15-lipoxygenase, partial | Homo sapiens (human) | Potency | 16.9152 | 1 | 4 |
| 67.9K protein | Vaccinia virus | Potency | 1.1974 | 2 | 8 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 46.6255 | 2 | 5 |
| acid sphingomyelinase | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 3.2408 | 1 | 3 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 26.3649 | 1 | 10 |
| alpha-galactosidase | Homo sapiens (human) | Potency | 27.9709 | 1 | 3 |
| Alpha-synuclein | Homo sapiens (human) | Potency | 5.8048 | 1 | 1 |
| AR protein | Homo sapiens (human) | Potency | 19.8089 | 12 | 54 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 48.2920 | 2 | 7 |
| arylsulfatase A | Homo sapiens (human) | Potency | 0.3180 | 1 | 4 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 20.3933 | 4 | 6 |
| Ataxin-2 | Homo sapiens (human) | Potency | 16.0964 | 2 | 6 |
| ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 17.0427 | 2 | 5 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 16.7614 | 2 | 5 |
| atrial natriuretic peptide receptor 1 precursor | Homo sapiens (human) | Potency | 3.0131 | 1 | 1 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 6.6539 | 2 | 6 |
| bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 75.0594 | 1 | 2 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 5.4140 | 1 | 2 |
| caspase-1 isoform alpha precursor | Homo sapiens (human) | Potency | 15.8489 | 1 | 1 |
| caspase-3 | Cricetulus griseus (Chinese hamster) | Potency | 0.2660 | 1 | 1 |
| caspase-3 | Homo sapiens (human) | Potency | 5.4140 | 1 | 2 |
| Caspase-7 | Cricetulus griseus (Chinese hamster) | Potency | 0.2660 | 1 | 1 |
| Caspase-7 | Homo sapiens (human) | Potency | 15.8489 | 1 | 1 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 18.3232 | 3 | 15 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 0.1000 | 2 | 2 |
| Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 25.5259 | 1 | 10 |
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 19.8461 | 2 | 5 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 34.3521 | 2 | 3 |
| Chain A, HADH2 protein | Homo sapiens (human) | Potency | 23.3291 | 2 | 5 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 62.3032 | 1 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 18.1976 | 2 | 9 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 12.5594 | 1 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 34.6152 | 1 | 5 |
| Chain B, HADH2 protein | Homo sapiens (human) | Potency | 23.3291 | 2 | 5 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 79.0277 | 2 | 10 |
| ClpP | Bacillus subtilis | Potency | 23.7358 | 1 | 2 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 8.1548 | 1 | 2 |
| cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 14.8364 | 1 | 6 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 17.4432 | 1 | 8 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 15.1653 | 1 | 4 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 10.8126 | 2 | 12 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 16.4545 | 2 | 6 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 22.6711 | 1 | 6 |
| D(1A) dopamine receptor | Homo sapiens (human) | Potency | 0.9199 | 1 | 1 |
| D(1A) dopamine receptor | Sus scrofa (pig) | Potency | 14.6892 | 1 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | Potency | 13.3025 | 1 | 5 |
| DNA polymerase beta | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
| DNA polymerase eta isoform 1 | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 64.1546 | 1 | 5 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 46.7791 | 1 | 2 |
| dopamine D1 receptor | Homo sapiens (human) | Potency | 6.4052 | 1 | 2 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 15.3603 | 10 | 70 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 11.5325 | 2 | 10 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 18.1151 | 9 | 57 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 17.7789 | 1 | 13 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 17.8379 | 4 | 20 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 10.9107 | 4 | 10 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 47.6708 | 1 | 3 |
| Fumarate hydratase | Homo sapiens (human) | Potency | 19.4030 | 1 | 2 |
| G | Vesicular stomatitis virus | Potency | 17.4432 | 1 | 8 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| GALC protein | Homo sapiens (human) | Potency | 0.7079 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 10.8126 | 1 | 6 |
| geminin | Homo sapiens (human) | Potency | 15.9344 | 2 | 14 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 12.7664 | 2 | 13 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 2.5119 | 1 | 1 |
| GLS protein | Homo sapiens (human) | Potency | 21.6957 | 1 | 8 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 14.2104 | 4 | 13 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 17.4513 | 1 | 6 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 15.5669 | 2 | 22 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 22.7053 | 1 | 8 |
| histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 29.8493 | 2 | 2 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 53.8687 | 2 | 6 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 17.4432 | 1 | 8 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 14.4823 | 1 | 6 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 8.7699 | 2 | 6 |
| IDH1 | Homo sapiens (human) | Potency | 9.8531 | 1 | 3 |
| importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 112.2020 | 1 | 1 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 17.4432 | 1 | 16 |
| Inositol monophosphatase 1 | Rattus norvegicus (Norway rat) | Potency | 5.0119 | 1 | 1 |
| Integrin alpha-IIb | Homo sapiens (human) | Potency | 0.1000 | 1 | 1 |
| Integrin beta-3 | Homo sapiens (human) | Potency | 0.1000 | 1 | 1 |
| Interferon beta | Homo sapiens (human) | Potency | 12.1557 | 3 | 24 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 9.6973 | 2 | 9 |
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 30.3756 | 3 | 14 |
| M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 56.2565 | 1 | 3 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 23.6387 | 2 | 10 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 19.9526 | 1 | 1 |
| muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 3.1623 | 1 | 1 |
| muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 43.4879 | 1 | 3 |
| neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 0.3162 | 1 | 1 |
| NFKB1 protein, partial | Homo sapiens (human) | Potency | 0.0100 | 2 | 2 |
| nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 2.4852 | 1 | 4 |
| NPC intracellular cholesterol transporter 1 precursor | Homo sapiens (human) | Potency | 7.3946 | 1 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 20.3730 | 3 | 23 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 8.1104 | 2 | 3 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 32.9572 | 1 | 2 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 84.1267 | 1 | 1 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 18.9966 | 1 | 2 |
| nuclear receptor subfamily 1, group I, member 2 | Rattus norvegicus (Norway rat) | Potency | 14.1254 | 1 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 28.8189 | 2 | 23 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 58.6544 | 1 | 2 |
| Parkin | Homo sapiens (human) | Potency | 10.8383 | 2 | 3 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Potency | 23.9341 | 1 | 1 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 5.7764 | 2 | 7 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 16.2239 | 5 | 19 |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 21.0290 | 4 | 9 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 55.8554 | 1 | 5 |
| plasminogen precursor | Mus musculus (house mouse) | Potency | 2.5119 | 1 | 1 |
| polyprotein | Zika virus | Potency | 19.4030 | 1 | 2 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | Potency | 26.2000 | 1 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 18.8541 | 1 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 14.1254 | 1 | 1 |
| PPM1D protein | Homo sapiens (human) | Potency | 7.1556 | 1 | 8 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 28.6034 | 3 | 17 |
| pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 50.1187 | 1 | 2 |
| progesterone receptor | Homo sapiens (human) | Potency | 13.4684 | 3 | 8 |
| Rap guanine nucleotide exchange factor 3 | Homo sapiens (human) | Potency | 2.5119 | 1 | 1 |
| Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) | Potency | 50.1187 | 1 | 1 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 18.8683 | 2 | 12 |
| ras-related protein Rab-9A | Homo sapiens (human) | Potency | 3.2643 | 1 | 1 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 21.8293 | 1 | 2 |
| relaxin receptor 1 isoform 1 | Homo sapiens (human) | Potency | 12.5893 | 1 | 1 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 28.2955 | 3 | 16 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 11.5399 | 4 | 21 |
| serine/threonine-protein kinase mTOR isoform 1 | Homo sapiens (human) | Potency | 19.0975 | 3 | 3 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 22.6988 | 2 | 5 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 22.6988 | 2 | 5 |
| Smad3 | Homo sapiens (human) | Potency | 0.3353 | 1 | 2 |
| snurportin-1 | Homo sapiens (human) | Potency | 112.2020 | 1 | 1 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 21.6541 | 1 | 7 |
| survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 0.6051 | 1 | 3 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 19.6334 | 1 | 6 |
| TDP1 protein | Homo sapiens (human) | Potency | 7.2297 | 2 | 28 |
| thioredoxin glutathione reductase | Schistosoma mansoni | Potency | 50.1187 | 1 | 1 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 19.9249 | 3 | 9 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 16.6152 | 3 | 16 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 39.8107 | 2 | 2 |
| transcriptional regulator ERG isoform 3 | Homo sapiens (human) | Potency | 35.7168 | 1 | 2 |
| tyrosine-protein kinase Yes | Homo sapiens (human) | Potency | 4.5054 | 1 | 2 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | Homo sapiens (human) | Potency | 13.3025 | 1 | 5 |
| urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 2.5119 | 1 | 1 |
| urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 2.5119 | 1 | 1 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 119.7498 | 2 | 5 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 11.6245 | 2 | 3 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 20.2566 | 5 | 15 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 41.1069 | 1 | 5 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 17.4513 | 1 | 6 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| [Tau protein] kinase | Sus scrofa (pig) | IC50 | 0.3600 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | IC50 | 10.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | IC50 | 0.0011 | 1 | 1 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | IC50 | 0.0146 | 2 | 2 |
| 5'-nucleotidase | Rattus norvegicus (Norway rat) | IC50 | 20.2000 | 1 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | Homo sapiens (human) | Ki | 62.1500 | 1 | 4 |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | IC50 | 77.0000 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | IC50 | 2.9270 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | Ki | 2.9030 | 1 | 1 |
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | IC50 | 1.6000 | 1 | 1 |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | IC50 | 2.7425 | 3 | 4 |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | Ki | 0.8100 | 1 | 1 |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | IC50 | 8.1500 | 2 | 3 |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | Ki | 0.2200 | 1 | 1 |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | IC50 | 0.5380 | 3 | 4 |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | Ki | 0.3000 | 1 | 1 |
| Aldo-keto reductase family 1 member C4 | Homo sapiens (human) | IC50 | 100.0000 | 2 | 3 |
| Alkaline phosphatase, placental type | Homo sapiens (human) | IC50 | 400.0000 | 4 | 4 |
| Alkaline phosphatase, tissue-nonspecific isozyme | Homo sapiens (human) | IC50 | 16.1525 | 4 | 4 |
| Alkaline phosphatase, tissue-nonspecific isozyme | Homo sapiens (human) | Ki | 16.0000 | 1 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | Bos taurus (cattle) | IC50 | 19.4060 | 5 | 5 |
| Alkaline phosphatase, tissue-nonspecific isozyme | Bos taurus (cattle) | Ki | 1.8100 | 1 | 1 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 9.3400 | 1 | 1 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 9.3400 | 1 | 1 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | IC50 | 4.7720 | 1 | 1 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 9.3400 | 1 | 1 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | Ki | 2.3460 | 1 | 1 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | Ki | 5.4108 | 1 | 2 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | Ki | 52.0332 | 1 | 2 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | Ki | 12.9244 | 1 | 2 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | IC50 | 165.8000 | 1 | 1 |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | IC50 | 13.0000 | 2 | 2 |
| Amyloid-beta precursor protein | Homo sapiens (human) | IC50 | 9.9000 | 2 | 2 |
| Androgen receptor | Homo sapiens (human) | IC50 | 1.0000 | 2 | 2 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | IC50 | 6.2350 | 2 | 2 |
| AP2-associated protein kinase 1 | Homo sapiens (human) | IC50 | 0.0170 | 1 | 1 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 108.7632 | 2 | 10 |
| ATP-binding cassette sub-family C member 3 | Rattus norvegicus (Norway rat) | Ki | 90.0000 | 1 | 1 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 3.0464 | 41 | 42 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | IC50 | 2.7500 | 4 | 4 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | Ki | 1.7183 | 6 | 6 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | Ki | 3.5750 | 2 | 2 |
| Beta-carbonic anhydrase 1 | Mycobacterium tuberculosis H37Rv | Ki | 12.9700 | 3 | 3 |
| Beta-lactamase | Escherichia coli K-12 | IC50 | 350.0000 | 1 | 1 |
| Beta-secretase 1 | Homo sapiens (human) | IC50 | 9.8500 | 2 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum K1 | IC50 | 0.0840 | 1 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | IC50 | 5.7614 | 29 | 39 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Trypanosoma cruzi | IC50 | 0.1100 | 1 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Leishmania major | Ki | 0.0001 | 1 | 1 |
| Bifunctional purine biosynthesis protein ATIC | Homo sapiens (human) | IC50 | 10.0050 | 2 | 2 |
| Bifunctional purine biosynthesis protein ATIC | Homo sapiens (human) | Ki | 0.8800 | 1 | 1 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 278.6570 | 8 | 27 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 666.8667 | 1 | 3 |
| Bile salt export pump | Homo sapiens (human) | Ki | 9.5000 | 1 | 1 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | Ki | 0.3000 | 1 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | IC50 | 24.6546 | 3 | 3 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | Ki | 0.5000 | 1 | 1 |
| C-C chemokine receptor type 2 | Homo sapiens (human) | IC50 | 0.0059 | 2 | 2 |
| C-C chemokine receptor type 5 | Homo sapiens (human) | IC50 | 0.0030 | 1 | 1 |
| C-C chemokine receptor type 5 | Mus musculus (house mouse) | IC50 | 0.0002 | 1 | 1 |
| C-C chemokine receptor type 7 | Homo sapiens (human) | IC50 | 0.0031 | 1 | 1 |
| Calcineurin subunit B type 1 | Homo sapiens (human) | IC50 | 34.0000 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | IC50 | 505.0000 | 2 | 2 |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | IC50 | 505.0000 | 2 | 2 |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | IC50 | 505.0000 | 2 | 2 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 85.0808 | 5 | 12 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | Ki | 11.2700 | 3 | 3 |
| Canalicular multispecific organic anion transporter 1 | Rattus norvegicus (Norway rat) | Ki | 207.1920 | 5 | 5 |
| Carbonic anhydrase | Candida albicans SC5314 | Ki | 0.7002 | 3 | 4 |
| Carbonic anhydrase | Methanosarcina thermophila | Ki | 0.1850 | 2 | 2 |
| Carbonic anhydrase | Methanothermobacter thermautotrophicus str. Delta H | Ki | 61.0000 | 1 | 1 |
| Carbonic anhydrase | Saccharomyces cerevisiae S288C | Ki | 0.6540 | 1 | 1 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 5.7100 | 1 | 1 |
| Carbonic anhydrase | Anopheles gambiae (African malaria mosquito) | Ki | 0.1640 | 1 | 1 |
| Carbonic anhydrase | Astrosclera willeyana | Ki | 0.5170 | 1 | 1 |
| Carbonic anhydrase | Cryptococcus neoformans var. grubii | Ki | 0.7040 | 1 | 1 |
| Carbonic anhydrase | Mycobacterium tuberculosis H37Rv | Ki | 7.8100 | 1 | 1 |
| Carbonic anhydrase | Nakaseomyces glabratus CBS 138 | Ki | 0.0970 | 1 | 1 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 0.0287 | 2 | 2 |
| Carbonic anhydrase | Sulfurihydrogenibium sp. YO3AOP1 | Ki | 0.0053 | 1 | 1 |
| Carbonic anhydrase 1 | Homo sapiens (human) | IC50 | 130.4833 | 4 | 7 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 50.7955 | 35 | 36 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Ki | 0.0130 | 5 | 5 |
| Carbonic anhydrase 13 | Homo sapiens (human) | Ki | 0.4250 | 1 | 1 |
| Carbonic anhydrase 13 | Mus musculus (house mouse) | Ki | 0.4250 | 1 | 1 |
| Carbonic anhydrase 14 | Homo sapiens (human) | Ki | 0.1070 | 1 | 1 |
| Carbonic anhydrase 15 | Mus musculus (house mouse) | Ki | 0.2347 | 2 | 3 |
| Carbonic anhydrase 2 | Homo sapiens (human) | IC50 | 101.2554 | 5 | 8 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 1.0789 | 41 | 42 |
| Carbonic anhydrase 2 | Mycobacterium tuberculosis H37Rv | Ki | 0.6820 | 2 | 2 |
| Carbonic anhydrase 3 | Homo sapiens (human) | Ki | 433.0000 | 2 | 2 |
| Carbonic anhydrase 4 | Bos taurus (cattle) | IC50 | 11.0126 | 3 | 5 |
| Carbonic anhydrase 4 | Bos taurus (cattle) | Ki | 0.3400 | 2 | 2 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Ki | 1.0067 | 3 | 3 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | Ki | 0.9120 | 1 | 1 |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | Ki | 0.0880 | 1 | 1 |
| Carbonic anhydrase 6 | Homo sapiens (human) | Ki | 0.4455 | 3 | 4 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Ki | 3.9000 | 4 | 4 |
| Carbonic anhydrase 9 | Homo sapiens (human) | IC50 | 0.0270 | 2 | 2 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Ki | 2.7827 | 9 | 10 |
| Carbonic anhydrase, alpha family | Hydrogenovibrio crunogenus XCL-2 | Ki | 0.5290 | 1 | 1 |
| Casein kinase II subunit alpha | Homo sapiens (human) | IC50 | 0.0200 | 1 | 1 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | IC50 | 0.0200 | 1 | 1 |
| Casein kinase II subunit beta | Homo sapiens (human) | IC50 | 0.0200 | 1 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | IC50 | 3.2600 | 1 | 1 |
| CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | IC50 | 0.5140 | 1 | 1 |
| Chain A, Carbonic anhydrase II | Homo sapiens (human) | Ki | 0.0430 | 1 | 1 |
| Chain A, Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform | Homo sapiens (human) | IC50 | 0.0080 | 1 | 2 |
| Chain A, Protein (glycogen Phosphorylase) | Oryctolagus cuniculus (rabbit) | IC50 | 1.0000 | 1 | 1 |
| Chain A, Tyrosine-protein kinase | Homo sapiens (human) | IC50 | 0.0116 | 1 | 4 |
| Chain A, Tyrosine-protein kinase JAK2 | Homo sapiens (human) | IC50 | 0.0116 | 1 | 2 |
| Cyclic GMP-AMP synthase | Homo sapiens (human) | IC50 | 23.0000 | 1 | 1 |
| Cyclin homolog | Herpesvirus saimiri (strain 11) | IC50 | 0.1850 | 1 | 4 |
| Cyclin-A1 | Homo sapiens (human) | IC50 | 0.7850 | 2 | 2 |
| Cyclin-A1 | Homo sapiens (human) | Ki | 0.1900 | 1 | 1 |
| Cyclin-A2 | Homo sapiens (human) | IC50 | 0.3441 | 9 | 10 |
| Cyclin-A2 | Homo sapiens (human) | Ki | 0.1900 | 1 | 1 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | IC50 | 0.1159 | 29 | 35 |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | IC50 | 0.2067 | 3 | 6 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | Ki | 0.0550 | 2 | 2 |
| Cyclin-dependent kinase 12 | Homo sapiens (human) | IC50 | 1.3700 | 1 | 1 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | IC50 | 8.1751 | 37 | 44 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | Ki | 0.1400 | 3 | 3 |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | IC50 | 0.1589 | 27 | 34 |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | Ki | 0.0400 | 1 | 1 |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | IC50 | 0.1765 | 5 | 8 |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | IC50 | 0.1572 | 6 | 9 |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | IC50 | 0.3365 | 6 | 6 |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | IC50 | 0.0209 | 17 | 17 |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | Ki | 0.0030 | 2 | 2 |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | IC50 | 0.9935 | 9 | 12 |
| Cyclin-G-associated kinase | Homo sapiens (human) | IC50 | 0.1360 | 1 | 1 |
| Cyclin-H | Homo sapiens (human) | IC50 | 0.3413 | 3 | 3 |
| Cyclin-K | Homo sapiens (human) | IC50 | 1.3700 | 1 | 1 |
| Cyclin-T1 | Homo sapiens (human) | IC50 | 0.0243 | 10 | 10 |
| Cyclin-T1 | Homo sapiens (human) | Ki | 0.0030 | 1 | 1 |
| Cyclooxygenase-2 | Canis lupus familiaris (dog) | IC50 | 3.7900 | 1 | 1 |
| Cystathionine gamma-lyase | Homo sapiens (human) | IC50 | 270.0000 | 1 | 1 |
| Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 0.1100 | 2 | 2 |
| Cytochrome c oxidase subunit 1 | Ovis aries (sheep) | IC50 | 96.2000 | 1 | 1 |
| Cytochrome c oxidase subunit 2 | Homo sapiens (human) | IC50 | 1.1000 | 1 | 1 |
| Cytochrome P450 11B1, mitochondrial | Bos taurus (cattle) | IC50 | 0.0012 | 2 | 5 |
| Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 64.5000 | 2 | 2 |
| Cytochrome P450 2A6 | Homo sapiens (human) | IC50 | 0.0120 | 1 | 1 |
| Cytochrome P450 2C19 | Homo sapiens (human) | IC50 | 12.0005 | 3 | 3 |
| Cytochrome P450 2C8 | Homo sapiens (human) | IC50 | 0.0014 | 1 | 1 |
| Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 41.9500 | 3 | 4 |
| Cytochrome P450 2C9 | Homo sapiens (human) | Ki | 22.5667 | 3 | 3 |
| Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 43.0012 | 3 | 3 |
| Cytochrome P450 2J2 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 2 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 155.2922 | 7 | 9 |
| Cytochrome P450 3A4 | Homo sapiens (human) | Ki | 6.0550 | 2 | 4 |
| Cytochrome P450 3A43 | Homo sapiens (human) | IC50 | 2.0600 | 1 | 1 |
| Cytochrome P450 3A43 | Homo sapiens (human) | Ki | 7.6000 | 1 | 2 |
| Cytochrome P450 3A5 | Homo sapiens (human) | IC50 | 2.0600 | 1 | 1 |
| Cytochrome P450 3A5 | Homo sapiens (human) | Ki | 7.6000 | 1 | 2 |
| Cytochrome P450 3A7 | Homo sapiens (human) | IC50 | 2.0600 | 1 | 1 |
| Cytochrome P450 3A7 | Homo sapiens (human) | Ki | 7.6000 | 1 | 2 |
| Cytoplasmic tyrosine-protein kinase BMX | Homo sapiens (human) | IC50 | 0.0815 | 1 | 8 |
| Delta carbonic anhydrase | Conticribra weissflogii | Ki | 0.3780 | 1 | 1 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0030 | 1 | 1 |
| Delta-type opioid receptor | Mus musculus (house mouse) | Ki | 27.0215 | 2 | 2 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.0430 | 1 | 1 |
| Dihydrofolate reductase | Enterococcus faecium | IC50 | 0.0014 | 1 | 1 |
| Dihydrofolate reductase | Escherichia coli K-12 | IC50 | 4.1688 | 24 | 34 |
| Dihydrofolate reductase | Gallus gallus (chicken) | IC50 | 0.0545 | 2 | 2 |
| Dihydrofolate reductase | Homo sapiens (human) | IC50 | 1.5079 | 80 | 94 |
| Dihydrofolate reductase | Lacticaseibacillus casei | IC50 | 0.0138 | 29 | 30 |
| Dihydrofolate reductase | Mus musculus (house mouse) | IC50 | 0.0331 | 11 | 11 |
| Dihydrofolate reductase | Mycobacterium tuberculosis H37Rv | IC50 | 0.0174 | 3 | 3 |
| Dihydrofolate reductase | Pneumocystis carinii | IC50 | 0.0717 | 12 | 13 |
| Dihydrofolate reductase | Rattus norvegicus (Norway rat) | IC50 | 0.0047 | 10 | 11 |
| Dihydrofolate reductase | Escherichia coli K-12 | Ki | 34.5460 | 5 | 5 |
| Dihydrofolate reductase | Homo sapiens (human) | Ki | 6.3684 | 12 | 12 |
| Dihydrofolate reductase | Lacticaseibacillus casei | Ki | 0.0000 | 1 | 1 |
| Dihydrofolate reductase | Mus musculus (house mouse) | Ki | 0.2167 | 17 | 18 |
| Dihydrofolate reductase | Pneumocystis carinii | Ki | 0.0000 | 1 | 1 |
| Dihydrofolate reductase | Staphylococcus aureus | Ki | 0.0005 | 2 | 2 |
| Dihydrofolate reductase | Bacillus anthracis | IC50 | 0.0136 | 1 | 2 |
| Dihydrofolate reductase | Bos taurus (cattle) | IC50 | 611.0529 | 13 | 13 |
| Dihydroorotate dehydrogenase (quinone), mitochondrial | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| DNA ligase | Tequatrovirus T4 | IC50 | 823.0000 | 2 | 4 |
| DNA ligase 1 | Homo sapiens (human) | IC50 | 823.0000 | 2 | 4 |
| DNA ligase A | Mycobacterium tuberculosis H37Rv | IC50 | 823.0000 | 2 | 4 |
| Dual specificity mitogen-activated protein kinase kinase 7 | Homo sapiens (human) | IC50 | 0.0815 | 1 | 8 |
| Dual specificity protein kinase CLK1 | Homo sapiens (human) | IC50 | 0.0700 | 1 | 1 |
| Dual specificity protein kinase CLK1 | Mus musculus (house mouse) | IC50 | 1.3000 | 1 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | IC50 | 0.8150 | 2 | 2 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Rattus norvegicus (Norway rat) | IC50 | 0.3000 | 1 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B | Homo sapiens (human) | IC50 | 0.0800 | 1 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Homo sapiens (human) | IC50 | 0.1000 | 1 | 1 |
| Epidermal growth factor receptor | Homo sapiens (human) | IC50 | 5.4809 | 6 | 13 |
| Estrogen receptor 1 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 2 |
| Fatty acid-binding protein, intestinal | Homo sapiens (human) | Ki | 8.9000 | 1 | 1 |
| Fatty acid-binding protein, liver | Rattus norvegicus (Norway rat) | Ki | 0.3175 | 2 | 2 |
| Fatty-acid amide hydrolase 1 | Mus musculus (house mouse) | IC50 | 0.0800 | 1 | 1 |
| fMet-Leu-Phe receptor | Homo sapiens (human) | IC50 | 7.6500 | 2 | 2 |
| Folate receptor alpha | Homo sapiens (human) | IC50 | 0.2262 | 4 | 4 |
| Folate receptor beta | Homo sapiens (human) | IC50 | 0.1585 | 4 | 4 |
| Folylpolyglutamate synthase, mitochondrial | Homo sapiens (human) | IC50 | 3.2000 | 1 | 1 |
| Folylpolyglutamate synthase, mitochondrial | Mus musculus (house mouse) | Ki | 166.0000 | 1 | 1 |
| G1/S-specific cyclin-D1 | Homo sapiens (human) | IC50 | 0.1837 | 18 | 25 |
| G1/S-specific cyclin-D2 | Homo sapiens (human) | IC50 | 0.1000 | 2 | 2 |
| G1/S-specific cyclin-D3 | Homo sapiens (human) | IC50 | 0.1983 | 3 | 3 |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | IC50 | 15.2146 | 16 | 22 |
| G1/S-specific cyclin-E2 | Homo sapiens (human) | IC50 | 55.3000 | 6 | 6 |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | IC50 | 0.2067 | 3 | 6 |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | IC50 | 0.1464 | 20 | 26 |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | IC50 | 0.1571 | 7 | 7 |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | IC50 | 0.1571 | 7 | 7 |
| Genome polyprotein | Zika virus | Ki | 92.3000 | 1 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | Homo sapiens (human) | Ki | 74.4500 | 1 | 2 |
| glucose-6-phosphate 1-dehydrogenase isoform b | Homo sapiens (human) | IC50 | 80.0000 | 1 | 1 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | IC50 | 67.6667 | 3 | 3 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | IC50 | 0.0006 | 1 | 1 |
| Glutathione reductase, mitochondrial | Homo sapiens (human) | Ki | 6.1000 | 1 | 1 |
| Glycogen phosphorylase, muscle form | Oryctolagus cuniculus (rabbit) | IC50 | 1.2000 | 1 | 1 |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | IC50 | 0.5250 | 2 | 2 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | IC50 | 2.9888 | 4 | 4 |
| Glycogen synthase kinase-3 beta | Rattus norvegicus (Norway rat) | IC50 | 0.1850 | 1 | 4 |
| Glycogen synthase kinase-3 beta | Sus scrofa (pig) | IC50 | 0.3600 | 1 | 1 |
| Histidine decarboxylase | Rattus norvegicus (Norway rat) | IC50 | 0.0014 | 1 | 1 |
| Histidine-rich protein PFHRP-II | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 396,967.5905 | 13 | 13 |
| Ileal sodium/bile acid cotransporter | Homo sapiens (human) | Ki | 24.0000 | 1 | 1 |
| Insulin receptor | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Integrase | Human immunodeficiency virus 1 | IC50 | 100.0000 | 2 | 2 |
| Interleukin-2 | Mus musculus (house mouse) | IC50 | 0.0050 | 1 | 1 |
| Intestinal-type alkaline phosphatase | Bos taurus (cattle) | IC50 | 171.7220 | 5 | 5 |
| Intestinal-type alkaline phosphatase | Homo sapiens (human) | IC50 | 205.0420 | 5 | 5 |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0030 | 1 | 1 |
| La-related protein 7 | Homo sapiens (human) | Ki | 0.0030 | 1 | 1 |
| large T antigen | Betapolyomavirus macacae | IC50 | 6.2000 | 1 | 1 |
| Lysyl oxidase homolog 2 | Homo sapiens (human) | IC50 | 0.5650 | 13 | 13 |
| Lysyl oxidase homolog 2 | Mus musculus (house mouse) | IC50 | 0.1280 | 1 | 1 |
| Lysyl oxidase homolog 2 | Rattus norvegicus (Norway rat) | IC50 | 0.1270 | 1 | 1 |
| Lysyl oxidase homolog 3 | Homo sapiens (human) | IC50 | 0.2400 | 2 | 2 |
| Lysyl oxidase homolog 4 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Malate dehydrogenase, cytoplasmic | Homo sapiens (human) | IC50 | 225.0000 | 1 | 1 |
| MAP kinase-activated protein kinase 2 | Homo sapiens (human) | IC50 | 10.0000 | 2 | 2 |
| MAP kinase-activated protein kinase 5 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | IC50 | 0.2000 | 1 | 1 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | IC50 | 3.1440 | 1 | 1 |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | IC50 | 3.3427 | 3 | 3 |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | IC50 | 16.0000 | 1 | 1 |
| Mitogen-activated protein kinase 8 | Homo sapiens (human) | IC50 | 7.7100 | 2 | 2 |
| MO15-related protein kinase Pfmrk | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 150.0000 | 1 | 1 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0030 | 1 | 1 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.0430 | 1 | 1 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 54.0000 | 1 | 1 |
| Multidrug resistance associated protein | Homo sapiens (human) | Ki | 1,200.0000 | 1 | 1 |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | IC50 | 3.5082 | 10 | 10 |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | Ki | 5.0000 | 1 | 1 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 129.7667 | 1 | 9 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | Ki | 12.3042 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | IC50 | 2.9510 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | Ki | 3.6183 | 2 | 3 |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | Ki | 4.0488 | 1 | 2 |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | Ki | 5.6249 | 1 | 2 |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | Ki | 20.9151 | 1 | 2 |
| Myc proto-oncogene protein | Homo sapiens (human) | IC50 | 403.0000 | 1 | 1 |
| Myeloperoxidase | Homo sapiens (human) | IC50 | 1.5950 | 2 | 2 |
| NACHT, LRR and PYD domains-containing protein 3 | Mus musculus (house mouse) | IC50 | 25.0000 | 1 | 1 |
| Nicotinate phosphoribosyltransferase | Homo sapiens (human) | Ki | 0.0001 | 1 | 2 |
| Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | GI50 | 1.5240 | 1 | 1 |
| Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | IC50 | 6.3900 | 44 | 64 |
| Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | Ki | 0.0063 | 5 | 5 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | Homo sapiens (human) | IC50 | 35.8790 | 2 | 2 |
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | IC50 | 18.0450 | 2 | 2 |
| Peptidyl-prolyl cis-trans isomerase A | Homo sapiens (human) | IC50 | 0.0252 | 12 | 12 |
| Peptidyl-prolyl cis-trans isomerase A | Homo sapiens (human) | Ki | 0.0645 | 8 | 8 |
| Peptidyl-prolyl cis-trans isomerase B | Homo sapiens (human) | IC50 | 0.0088 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase D | Homo sapiens (human) | IC50 | 0.0036 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase D | Homo sapiens (human) | Ki | 0.0129 | 4 | 4 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | Ki | 0.0200 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1B | Homo sapiens (human) | Ki | 0.0060 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP4 | Homo sapiens (human) | IC50 | 0.0160 | 1 | 1 |
| Peptidylglycine alpha-amidating monooxygenase | Rattus norvegicus (Norway rat) | Ki | 0.0060 | 1 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | IC50 | 1.7830 | 3 | 6 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Homo sapiens (human) | IC50 | 0.6676 | 2 | 5 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Homo sapiens (human) | IC50 | 0.1876 | 2 | 5 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | IC50 | 0.0947 | 4 | 7 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Mus musculus (house mouse) | IC50 | 0.5700 | 1 | 1 |
| Phosphoethanolamine N-methyltransferase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 554.0000 | 1 | 1 |
| Phospholipase A-2-activating protein | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | IC50 | 49.3333 | 3 | 3 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 2.5030 | 4 | 4 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | Ki | 4.3914 | 2 | 3 |
| Procathepsin L | Homo sapiens (human) | IC50 | 5.4700 | 1 | 1 |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | IC50 | 53.5489 | 14 | 25 |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | IC50 | 94.6225 | 7 | 12 |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | IC50 | 65.0000 | 1 | 2 |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | IC50 | 3.8250 | 4 | 4 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | IC50 | 25.8391 | 23 | 31 |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | IC50 | 0.1619 | 4 | 6 |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | IC50 | 65.0000 | 1 | 2 |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | IC50 | 3.8250 | 4 | 4 |
| Protein kinase C alpha type | Homo sapiens (human) | IC50 | 7.4667 | 6 | 6 |
| Protein kinase C alpha type | Rattus norvegicus (Norway rat) | IC50 | 14.0000 | 1 | 1 |
| Protein kinase C beta type | Homo sapiens (human) | IC50 | 19.0000 | 4 | 4 |
| Protein kinase C beta type | Rattus norvegicus (Norway rat) | IC50 | 14.0000 | 1 | 1 |
| Protein kinase C delta type | Homo sapiens (human) | IC50 | 7.9725 | 4 | 4 |
| Protein kinase C delta type | Rattus norvegicus (Norway rat) | IC50 | 14.0000 | 1 | 1 |
| Protein kinase C epsilon type | Homo sapiens (human) | IC50 | 7.8700 | 4 | 4 |
| Protein kinase C epsilon type | Rattus norvegicus (Norway rat) | IC50 | 14.0000 | 1 | 1 |
| Protein kinase C eta type | Homo sapiens (human) | IC50 | 19.0000 | 4 | 4 |
| Protein kinase C eta type | Rattus norvegicus (Norway rat) | IC50 | 14.0000 | 1 | 1 |
| Protein kinase C gamma type | Homo sapiens (human) | IC50 | 10.3333 | 3 | 3 |
| Protein kinase C gamma type | Rattus norvegicus (Norway rat) | IC50 | 14.0000 | 1 | 1 |
| Protein kinase C iota type | Homo sapiens (human) | IC50 | 10.3333 | 3 | 3 |
| Protein kinase C theta type | Homo sapiens (human) | IC50 | 10.3333 | 3 | 3 |
| Protein kinase C theta type | Rattus norvegicus (Norway rat) | IC50 | 14.0000 | 1 | 1 |
| Protein kinase C zeta type | Homo sapiens (human) | IC50 | 10.3333 | 3 | 3 |
| Protein kinase C zeta type | Rattus norvegicus (Norway rat) | IC50 | 14.0000 | 1 | 1 |
| Protein-arginine deiminase type-4 | Homo sapiens (human) | IC50 | 10,000.0000 | 1 | 1 |
| Protein-lysine 6-oxidase | Bos taurus (cattle) | IC50 | 1.9953 | 1 | 1 |
| Protein-lysine 6-oxidase | Homo sapiens (human) | IC50 | 33.7000 | 3 | 3 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | IC50 | 34.0000 | 1 | 1 |
| Proton-coupled folate transporter | Homo sapiens (human) | IC50 | 0.1208 | 2 | 2 |
| Pteridine reductase 1 | Leishmania major | Ki | 0.1095 | 2 | 2 |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | IC50 | 1.8280 | 2 | 9 |
| Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | IC50 | 0.0815 | 1 | 8 |
| Reduced folate transporter | Homo sapiens (human) | IC50 | 0.0120 | 2 | 2 |
| Reduced folate transporter | Homo sapiens (human) | Ki | 3.5000 | 1 | 1 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | IC50 | 5.4700 | 1 | 1 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | IC50 | 5.4700 | 1 | 1 |
| Replicase polyprotein 1ab | Human coronavirus 229E | IC50 | 5.4700 | 1 | 1 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 602.8450 | 4 | 6 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | IC50 | 1,794.7350 | 2 | 2 |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | IC50 | 0.4550 | 1 | 1 |
| Rho-associated protein kinase 2 | Homo sapiens (human) | IC50 | 3.4000 | 2 | 2 |
| Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | IC50 | 1.5000 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | IC50 | 62.0000 | 1 | 1 |
| Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Serine/threonine-protein kinase D1 | Homo sapiens (human) | IC50 | 10.3333 | 3 | 3 |
| Serine/threonine-protein kinase D3 | Homo sapiens (human) | IC50 | 10.3333 | 3 | 3 |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | IC50 | 0.2700 | 1 | 1 |
| Serine/threonine-protein kinase Sgk1 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | IC50 | 5.7600 | 1 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Homo sapiens (human) | IC50 | 0.1830 | 1 | 1 |
| Sigma intracellular receptor 2 | Rattus norvegicus (Norway rat) | IC50 | 0.0143 | 1 | 1 |
| Sigma intracellular receptor 2 | Homo sapiens (human) | Ki | 0.7506 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | Ki | 0.1027 | 1 | 2 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | IC50 | 2.9270 | 1 | 1 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | Ki | 2.9030 | 1 | 1 |
| Sodium/bile acid cotransporter | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Solute carrier family 22 member 11 | Homo sapiens (human) | Ki | 107.8000 | 1 | 1 |
| Solute carrier family 22 member 20 | Mus musculus (house mouse) | Ki | 599.7800 | 1 | 2 |
| Solute carrier family 22 member 6 | Homo sapiens (human) | IC50 | 20.5000 | 1 | 1 |
| Solute carrier family 22 member 6 | Homo sapiens (human) | Ki | 19.8000 | 1 | 1 |
| Solute carrier family 22 member 6 | Mus musculus (house mouse) | Ki | 896.1255 | 1 | 2 |
| Solute carrier family 22 member 6 | Rattus norvegicus (Norway rat) | Ki | 52.0000 | 1 | 1 |
| Solute carrier family 22 member 8 | Homo sapiens (human) | Ki | 413.1933 | 2 | 3 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | IC50 | 0.9500 | 5 | 5 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | Ki | 0.4845 | 4 | 4 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | IC50 | 1.3000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | Ki | 1.2000 | 1 | 1 |
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | IC50 | 37.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | Ki | 36.0000 | 1 | 1 |
| Spike glycoprotein | Betacoronavirus England 1 | IC50 | 5.4700 | 1 | 1 |
| Spike glycoprotein | Severe acute respiratory syndrome coronavirus 2 | IC50 | 3.5800 | 2 | 2 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | IC50 | 5.4700 | 1 | 1 |
| Substance-K receptor | Homo sapiens (human) | IC50 | 4.1390 | 1 | 1 |
| Substance-K receptor | Homo sapiens (human) | Ki | 1.3800 | 1 | 1 |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | IC50 | 29.0000 | 1 | 1 |
| Succinyl-diaminopimelate desuccinylase | Haemophilus influenzae Rd KW20 | IC50 | 50.0000 | 1 | 1 |
| Thymidylate synthase | Escherichia coli K-12 | IC50 | 11.4303 | 3 | 12 |
| Thymidylate synthase | Homo sapiens (human) | IC50 | 33.6082 | 12 | 21 |
| Thymidylate synthase | Lacticaseibacillus casei | IC50 | 158.1000 | 10 | 10 |
| Thymidylate synthase | Mus musculus (house mouse) | IC50 | 20.0000 | 2 | 2 |
| Thymidylate synthase | Homo sapiens (human) | Ki | 0.6000 | 1 | 1 |
| Thymidylate synthase | Mus musculus (house mouse) | Ki | 45.0000 | 1 | 1 |
| Thymidylate synthase | Escherichia coli | IC50 | 60.6000 | 3 | 3 |
| Thymidylate synthase | Escherichia coli LF82 | IC50 | 18.0000 | 1 | 1 |
| Toll-like receptor 4 | Homo sapiens (human) | IC50 | 1.0400 | 1 | 1 |
| Toll-like receptor 7 | Homo sapiens (human) | IC50 | 3.4000 | 3 | 3 |
| Toll-like receptor 9 | Homo sapiens (human) | IC50 | 0.1100 | 1 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | Human alphaherpesvirus 1 (Herpes simplex virus type 1) | IC50 | 35.8790 | 2 | 2 |
| Transcription factor SOX-18 | Mus musculus (house mouse) | IC50 | 163.0000 | 2 | 2 |
| Transient receptor potential cation channel subfamily M member 2 | Homo sapiens (human) | IC50 | 124.0000 | 1 | 1 |
| Transmembrane protease serine 2 | Homo sapiens (human) | IC50 | 5.4700 | 1 | 1 |
| Transthyretin | Homo sapiens (human) | Ki | 0.0026 | 1 | 1 |
| Trifunctional purine biosynthetic protein adenosine-3 | Homo sapiens (human) | IC50 | 10.0050 | 2 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | Mus musculus (house mouse) | IC50 | 20.0000 | 2 | 2 |
| Tyrosine-protein kinase Blk | Homo sapiens (human) | IC50 | 0.0815 | 1 | 8 |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | IC50 | 0.0835 | 2 | 9 |
| Tyrosine-protein kinase CSK | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Tyrosine-protein kinase ITK/TSK | Homo sapiens (human) | IC50 | 1.7224 | 2 | 9 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | GI50 | 0.0953 | 1 | 1 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | IC50 | 0.0608 | 85 | 105 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | Ki | 0.0007 | 6 | 6 |
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | GI50 | 1.1570 | 1 | 1 |
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | IC50 | 0.1899 | 91 | 115 |
| Tyrosine-protein kinase JAK2 | Rattus norvegicus (Norway rat) | IC50 | 3.5700 | 2 | 2 |
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | Ki | 0.0008 | 5 | 5 |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | GI50 | 0.5030 | 1 | 1 |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | IC50 | 0.2721 | 69 | 86 |
| Tyrosine-protein kinase JAK3 | Mus musculus (house mouse) | IC50 | 0.6640 | 5 | 5 |
| Tyrosine-protein kinase JAK3 | Rattus norvegicus (Norway rat) | IC50 | 1.2000 | 1 | 1 |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | Ki | 0.0004 | 6 | 6 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | IC50 | 3.8960 | 5 | 5 |
| Tyrosine-protein kinase Tec | Homo sapiens (human) | IC50 | 0.0815 | 1 | 8 |
| Tyrosine-protein kinase TXK | Homo sapiens (human) | IC50 | 0.0815 | 1 | 8 |
| Tyrosine-protein kinase ZAP-70 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1-6 | Homo sapiens (human) | IC50 | 211.8333 | 1 | 6 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | IC50 | 211.8333 | 1 | 6 |
| UDP-glucuronosyltransferase 1A4 | Homo sapiens (human) | IC50 | 211.8333 | 1 | 6 |
| UDP-glucuronosyltransferase 2B10 | Homo sapiens (human) | IC50 | 211.8333 | 1 | 6 |
| UDP-glucuronosyltransferase 2B7 | Homo sapiens (human) | IC50 | 211.8333 | 1 | 6 |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | IC50 | 0.4000 | 1 | 1 |
| Vitamin K-dependent protein C | Homo sapiens (human) | IC50 | 0.1429 | 3 | 14 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 26S proteasome regulatory subunit 6B | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| 3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| 5-hydroxytryptamine receptor 2A | Mus musculus (house mouse) | EC50 | 5.3360 | 1 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | Homo sapiens (human) | Kd | 17.6600 | 4 | 10 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| 5'-AMP-activated protein kinase subunit gamma-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 5 |
| 5'-AMP-activated protein kinase subunit gamma-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| AarF domain-containing protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Actin-related protein 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Actin-related protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Activated CDC42 kinase 1 | Homo sapiens (human) | Kd | 18.2784 | 3 | 11 |
| Activin receptor type-1 | Homo sapiens (human) | Kd | 17.0889 | 3 | 9 |
| Activin receptor type-1B | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Activin receptor type-2A | Homo sapiens (human) | Kd | 8.6200 | 2 | 5 |
| Activin receptor type-2B | Homo sapiens (human) | Kd | 17.2000 | 3 | 9 |
| Acyl-CoA dehydrogenase family member 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Acyl-CoA dehydrogenase family member 11 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Adenine phosphoribosyltransferase | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Adenosine kinase | Homo sapiens (human) | Kd | 23.1102 | 1 | 4 |
| Adenylate kinase 2, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 5 |
| ADP/ATP translocase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| ADP/ATP translocase 3 | Homo sapiens (human) | Kd | 22.5015 | 1 | 4 |
| ALK tyrosine kinase receptor | Homo sapiens (human) | Kd | 6.2680 | 2 | 5 |
| Angiopoietin-1 receptor | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | EC50 | 5.4411 | 1 | 9 |
| Ankyrin repeat and protein kinase domain-containing protein 1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| AP2-associated protein kinase 1 | Homo sapiens (human) | Kd | 9.3348 | 8 | 14 |
| ATP-dependent 6-phosphofructokinase, platelet type | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| ATP-dependent RNA helicase DDX1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| ATP-dependent RNA helicase DDX3X | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| ATP-dependent RNA helicase DDX42 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| ATP-dependent RNA helicase DHX30 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | EC50 | 25.7799 | 8 | 8 |
| Atypical kinase COQ8A, mitochondrial | Homo sapiens (human) | Kd | 17.1000 | 4 | 10 |
| Atypical kinase COQ8B, mitochondrial | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Aurora kinase A | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Aurora kinase B | Homo sapiens (human) | Kd | 18.2295 | 3 | 11 |
| Aurora kinase C | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| BDNF/NT-3 growth factors receptor | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Beta-adrenergic receptor kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| BMP-2-inducible protein kinase | Homo sapiens (human) | Kd | 12.4869 | 5 | 11 |
| Bone morphogenetic protein receptor type-1A | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Bone morphogenetic protein receptor type-1B | Homo sapiens (human) | Kd | 20.0643 | 2 | 7 |
| Bone morphogenetic protein receptor type-2 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Breakpoint cluster region protein | Homo sapiens (human) | Kd | 22.5195 | 1 | 4 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | EC50 | 1.7500 | 1 | 1 |
| Calcium-dependent protein kinase 1 | Plasmodium falciparum K1 | EC50 | 0.0680 | 1 | 1 |
| Calcium-dependent protein kinase 1 | Plasmodium falciparum 3D7 | Kd | 10.0000 | 1 | 3 |
| Calcium/calmodulin-dependent protein kinase kinase 1 | Homo sapiens (human) | Kd | 5.0295 | 3 | 6 |
| Calcium/calmodulin-dependent protein kinase kinase 2 | Homo sapiens (human) | Kd | 12.2559 | 4 | 10 |
| Calcium/calmodulin-dependent protein kinase type 1 | Homo sapiens (human) | Kd | 6.8667 | 3 | 6 |
| Calcium/calmodulin-dependent protein kinase type 1D | Homo sapiens (human) | Kd | 8.3200 | 2 | 5 |
| Calcium/calmodulin-dependent protein kinase type 1G | Homo sapiens (human) | Kd | 15.7143 | 3 | 7 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | Homo sapiens (human) | Kd | 4.7000 | 3 | 6 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta | Homo sapiens (human) | Kd | 7.8833 | 3 | 6 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta | Homo sapiens (human) | Kd | 15.4612 | 3 | 10 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma | Homo sapiens (human) | Kd | 14.7603 | 3 | 9 |
| Calcium/calmodulin-dependent protein kinase type IV | Homo sapiens (human) | Kd | 14.6511 | 3 | 9 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | Kd | 15.9552 | 3 | 9 |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | Kd | 30.0000 | 1 | 5 |
| cAMP-dependent protein kinase catalytic subunit PRKX | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| cAMP-dependent protein kinase type II-alpha regulatory subunit | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Carbonic anhydrase 2 | Homo sapiens (human) | EC50 | 0.0010 | 1 | 1 |
| Casein kinase I isoform alpha | Homo sapiens (human) | Kd | 20.4429 | 2 | 7 |
| Casein kinase I isoform alpha-like | Homo sapiens (human) | Kd | 8.4800 | 2 | 5 |
| Casein kinase I isoform delta | Homo sapiens (human) | Kd | 20.0000 | 3 | 10 |
| Casein kinase I isoform epsilon | Homo sapiens (human) | Kd | 15.5018 | 5 | 11 |
| Casein kinase I isoform gamma-1 | Homo sapiens (human) | Kd | 14.7726 | 3 | 9 |
| Casein kinase I isoform gamma-2 | Homo sapiens (human) | Kd | 17.0265 | 3 | 10 |
| Casein kinase I isoform gamma-3 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Casein kinase II subunit alpha | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | Kd | 16.2869 | 3 | 9 |
| Cell division control protein 2 homolog | Plasmodium falciparum 3D7 | Kd | 7.7667 | 1 | 3 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | Homo sapiens (human) | EC50 | 30.0000 | 2 | 2 |
| Cell division cycle 7-related protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| cGMP-dependent protein kinase 1 | Homo sapiens (human) | Kd | 20.0000 | 3 | 10 |
| cGMP-dependent protein kinase 2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Chain B, DIHYDROFOLATE REDUCTASE | Escherichia coli | Kd | 0.1344 | 1 | 5 |
| Choline-phosphate cytidylyltransferase A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Chromodomain-helicase-DNA-binding protein 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Citron Rho-interacting kinase | Homo sapiens (human) | Kd | 10.5910 | 3 | 9 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | Kd | 22.8790 | 1 | 4 |
| Cyclin-dependent kinase 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Cyclin-dependent kinase 11A | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Cyclin-dependent kinase 11B | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Cyclin-dependent kinase 12 | Homo sapiens (human) | Kd | 22.5392 | 1 | 4 |
| Cyclin-dependent kinase 13 | Homo sapiens (human) | Kd | 16.0349 | 2 | 7 |
| Cyclin-dependent kinase 14 | Homo sapiens (human) | Kd | 6.0440 | 2 | 5 |
| Cyclin-dependent kinase 15 | Homo sapiens (human) | Kd | 6.7767 | 1 | 3 |
| Cyclin-dependent kinase 16 | Homo sapiens (human) | Kd | 12.2152 | 4 | 10 |
| Cyclin-dependent kinase 17 | Homo sapiens (human) | Kd | 13.4407 | 3 | 9 |
| Cyclin-dependent kinase 18 | Homo sapiens (human) | Kd | 6.4400 | 2 | 5 |
| Cyclin-dependent kinase 19 | Homo sapiens (human) | Kd | 6.0228 | 2 | 5 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | EC50 | 0.0010 | 1 | 1 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | Kd | 12.2637 | 4 | 10 |
| Cyclin-dependent kinase 3 | Homo sapiens (human) | Kd | 16.7578 | 3 | 9 |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | Kd | 16.0012 | 3 | 10 |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | Kd | 23.3148 | 1 | 4 |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | Kd | 15.0721 | 3 | 10 |
| Cyclin-dependent kinase 8 | Homo sapiens (human) | Kd | 6.0480 | 2 | 5 |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | Kd | 13.3355 | 3 | 9 |
| Cyclin-dependent kinase-like 1 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Cyclin-dependent kinase-like 2 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Cyclin-dependent kinase-like 3 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Cyclin-dependent kinase-like 5 | Homo sapiens (human) | Kd | 18.3345 | 2 | 6 |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | Kd | 12.0370 | 4 | 10 |
| Cyclin-G-associated kinase | Homo sapiens (human) | Kd | 8.5455 | 9 | 15 |
| Cysteine--tRNA ligase, cytoplasmic | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Cytochrome c1, heme protein, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Cytochrome P450 3A4 | Homo sapiens (human) | Kd | 0.0130 | 1 | 1 |
| Cytoplasmic tyrosine-protein kinase BMX | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| dCTP pyrophosphatase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 5 |
| Death-associated protein kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Death-associated protein kinase 2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Death-associated protein kinase 3 | Homo sapiens (human) | Kd | 10.0000 | 3 | 7 |
| Delta(24)-sterol reductase | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Deoxycytidine kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Dihydrofolate reductase | Escherichia coli K-12 | EC50 | 0.0010 | 1 | 1 |
| Dihydrofolate reductase | Escherichia coli K-12 | Kd | 0.3062 | 10 | 10 |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | Kd | 14.8869 | 3 | 9 |
| DNA replication licensing factor MCM4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| DNA topoisomerase 2-beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| DnaJ homolog subfamily A member 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Dual serine/threonine and tyrosine protein kinase | Homo sapiens (human) | Kd | 8.0667 | 1 | 3 |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | Kd | 17.0429 | 3 | 10 |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | Kd | 20.0000 | 3 | 10 |
| Dual specificity mitogen-activated protein kinase kinase 3 | Homo sapiens (human) | Kd | 17.9111 | 3 | 9 |
| Dual specificity mitogen-activated protein kinase kinase 4 | Homo sapiens (human) | Kd | 14.6143 | 3 | 7 |
| Dual specificity mitogen-activated protein kinase kinase 5 | Homo sapiens (human) | Kd | 20.0257 | 2 | 7 |
| Dual specificity mitogen-activated protein kinase kinase 6 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Dual specificity mitogen-activated protein kinase kinase 7 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Dual specificity protein kinase CLK1 | Homo sapiens (human) | Kd | 12.6378 | 4 | 10 |
| Dual specificity protein kinase CLK2 | Homo sapiens (human) | Kd | 15.5800 | 4 | 10 |
| Dual specificity protein kinase CLK3 | Homo sapiens (human) | Kd | 13.8000 | 4 | 9 |
| Dual specificity protein kinase CLK4 | Homo sapiens (human) | Kd | 15.7143 | 3 | 7 |
| Dual specificity protein kinase TTK | Homo sapiens (human) | Kd | 13.3333 | 3 | 6 |
| Dual specificity testis-specific protein kinase 1 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Dual specificity testis-specific protein kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | Kd | 15.8553 | 2 | 7 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B | Homo sapiens (human) | Kd | 10.0280 | 3 | 6 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Dynamin-like 120 kDa protein, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| eIF-2-alpha kinase GCN2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| EKC/KEOPS complex subunit TP53RK | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Electron transfer flavoprotein subunit beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Elongation factor Tu, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Ephrin type-A receptor 1 | Homo sapiens (human) | Kd | 16.5375 | 3 | 8 |
| Ephrin type-A receptor 2 | Homo sapiens (human) | Kd | 17.2222 | 3 | 9 |
| Ephrin type-A receptor 3 | Homo sapiens (human) | Kd | 5.8200 | 2 | 5 |
| Ephrin type-A receptor 4 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Ephrin type-A receptor 5 | Homo sapiens (human) | Kd | 17.9545 | 4 | 11 |
| Ephrin type-A receptor 6 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Ephrin type-A receptor 7 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Ephrin type-A receptor 8 | Homo sapiens (human) | Kd | 8.3600 | 2 | 5 |
| Ephrin type-B receptor 1 | Homo sapiens (human) | Kd | 7.2833 | 3 | 6 |
| Ephrin type-B receptor 2 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Ephrin type-B receptor 3 | Homo sapiens (human) | Kd | 20.0000 | 3 | 10 |
| Ephrin type-B receptor 4 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Ephrin type-B receptor 6 | Homo sapiens (human) | Kd | 21.4286 | 2 | 7 |
| Epidermal growth factor receptor | Homo sapiens (human) | Kd | 9.0678 | 23 | 60 |
| Epithelial discoidin domain-containing receptor 1 | Homo sapiens (human) | Kd | 13.2128 | 4 | 10 |
| Eukaryotic peptide chain release factor GTP-binding subunit ERF3B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Eukaryotic translation initiation factor 2-alpha kinase 1 | Homo sapiens (human) | Kd | 8.5438 | 2 | 6 |
| Eukaryotic translation initiation factor 5B | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Exosome RNA helicase MTR4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Ferrochelatase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Fibroblast growth factor receptor 2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Fibroblast growth factor receptor 3 | Homo sapiens (human) | Kd | 10.0000 | 4 | 10 |
| Fibroblast growth factor receptor 4 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Focal adhesion kinase 1 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| G protein-coupled receptor kinase 4 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| G protein-coupled receptor kinase 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| General transcription and DNA repair factor IIH helicase subunit XPD | Homo sapiens (human) | Kd | 22.7302 | 1 | 4 |
| Glycine--tRNA ligase | Homo sapiens (human) | Kd | 30.0000 | 1 | 6 |
| Glycogen phosphorylase, brain form | Homo sapiens (human) | Kd | 23.3922 | 1 | 4 |
| Glycogen phosphorylase, liver form | Homo sapiens (human) | Kd | 23.0303 | 1 | 4 |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | Kd | 13.7301 | 3 | 9 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | Kd | 15.2200 | 3 | 10 |
| glycogen synthase kinase-3 beta isoform 1 | Homo sapiens (human) | EC50 | 300.0000 | 1 | 2 |
| GTP-binding nuclear protein Ran | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| GTP-binding protein (rab7) | Canis lupus familiaris (dog) | EC50 | 30.0000 | 1 | 1 |
| Guanine nucleotide-binding protein G(i) subunit alpha-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Heme oxygenase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Hepatocyte growth factor receptor | Homo sapiens (human) | Kd | 16.2500 | 5 | 16 |
| High affinity nerve growth factor receptor | Homo sapiens (human) | Kd | 17.5000 | 3 | 8 |
| High mobility group protein B1 | Homo sapiens (human) | Kd | 0.2620 | 2 | 2 |
| Homeodomain-interacting protein kinase 1 | Homo sapiens (human) | Kd | 8.9333 | 1 | 3 |
| Homeodomain-interacting protein kinase 2 | Homo sapiens (human) | Kd | 8.0667 | 1 | 3 |
| Homeodomain-interacting protein kinase 3 | Homo sapiens (human) | Kd | 8.1000 | 1 | 3 |
| Homeodomain-interacting protein kinase 4 | Homo sapiens (human) | Kd | 7.3333 | 1 | 3 |
| Hormonally up-regulated neu tumor-associated kinase | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Inhibitor of nuclear factor kappa-B kinase subunit alpha | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | Homo sapiens (human) | Kd | 17.3556 | 3 | 9 |
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Insulin receptor | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Insulin receptor-related protein | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Insulin-like growth factor 1 receptor | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Integrin-linked protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | Kd | 8.0800 | 2 | 5 |
| Interleukin-1 receptor-associated kinase 1 | Homo sapiens (human) | Kd | 20.0771 | 2 | 7 |
| Interleukin-1 receptor-associated kinase 3 | Homo sapiens (human) | Kd | 20.0000 | 3 | 10 |
| Interleukin-1 receptor-associated kinase 4 | Homo sapiens (human) | Kd | 20.2143 | 2 | 7 |
| Isoleucine--tRNA ligase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | Homo sapiens (human) | Kd | 4.1417 | 2 | 6 |
| Leukocyte tyrosine kinase receptor | Homo sapiens (human) | Kd | 6.8800 | 2 | 5 |
| Leukotriene C4 synthase | Cavia porcellus (domestic guinea pig) | Kd | 7.0667 | 1 | 3 |
| LIM domain kinase 1 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| LIM domain kinase 2 | Homo sapiens (human) | Kd | 20.9091 | 3 | 11 |
| Long-chain-fatty-acid--CoA ligase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | Kd | 5.1215 | 2 | 5 |
| Macrophage-stimulating protein receptor | Homo sapiens (human) | Kd | 21.4286 | 2 | 7 |
| Major prion protein | Homo sapiens (human) | EC50 | 4.0000 | 1 | 1 |
| MAP kinase-activated protein kinase 2 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| MAP kinase-activated protein kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| MAP kinase-activated protein kinase 5 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| MAP kinase-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| MAP kinase-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | Kd | 4.9833 | 3 | 6 |
| MAP/microtubule affinity-regulating kinase 3 | Homo sapiens (human) | Kd | 13.4318 | 3 | 9 |
| MAP/microtubule affinity-regulating kinase 4 | Homo sapiens (human) | Kd | 17.5000 | 3 | 8 |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | Kd | 7.7484 | 15 | 38 |
| Maternal embryonic leucine zipper kinase | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Megakaryocyte-associated tyrosine-protein kinase | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Membrane-associated progesterone receptor component 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | Homo sapiens (human) | Kd | 20.0000 | 3 | 10 |
| Microtubule-associated serine/threonine-protein kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Midasin | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Misshapen-like kinase 1 | Homo sapiens (human) | Kd | 16.2600 | 2 | 5 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | Kd | 14.6398 | 5 | 11 |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | Kd | 15.4764 | 5 | 11 |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | Kd | 15.4548 | 5 | 11 |
| Mitogen-activated protein kinase 15 | Homo sapiens (human) | Kd | 16.7400 | 3 | 9 |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Mitogen-activated protein kinase 4 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Mitogen-activated protein kinase 6 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Mitogen-activated protein kinase 7 | Homo sapiens (human) | Kd | 18.1240 | 3 | 10 |
| Mitogen-activated protein kinase 8 | Homo sapiens (human) | Kd | 14.7255 | 5 | 11 |
| Mitogen-activated protein kinase 9 | Homo sapiens (human) | Kd | 16.6693 | 5 | 12 |
| Mitogen-activated protein kinase kinase kinase 1 | Homo sapiens (human) | Kd | 17.4130 | 2 | 7 |
| Mitogen-activated protein kinase kinase kinase 10 | Homo sapiens (human) | Kd | 8.0800 | 2 | 5 |
| Mitogen-activated protein kinase kinase kinase 11 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Mitogen-activated protein kinase kinase kinase 12 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Mitogen-activated protein kinase kinase kinase 13 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Mitogen-activated protein kinase kinase kinase 15 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Mitogen-activated protein kinase kinase kinase 19 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Mitogen-activated protein kinase kinase kinase 2 | Homo sapiens (human) | Kd | 20.8714 | 2 | 7 |
| Mitogen-activated protein kinase kinase kinase 20 | Homo sapiens (human) | Kd | 17.8633 | 3 | 9 |
| Mitogen-activated protein kinase kinase kinase 3 | Homo sapiens (human) | Kd | 21.4143 | 2 | 7 |
| Mitogen-activated protein kinase kinase kinase 4 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Mitogen-activated protein kinase kinase kinase 5 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Mitogen-activated protein kinase kinase kinase 6 | Homo sapiens (human) | Kd | 21.4286 | 2 | 7 |
| Mitogen-activated protein kinase kinase kinase 7 | Homo sapiens (human) | Kd | 7.6333 | 1 | 3 |
| Mitogen-activated protein kinase kinase kinase 9 | Homo sapiens (human) | Kd | 8.2800 | 2 | 5 |
| Mitogen-activated protein kinase kinase kinase kinase 1 | Homo sapiens (human) | Kd | 17.4000 | 3 | 9 |
| Mitogen-activated protein kinase kinase kinase kinase 2 | Homo sapiens (human) | Kd | 19.2699 | 2 | 7 |
| Mitogen-activated protein kinase kinase kinase kinase 3 | Homo sapiens (human) | Kd | 17.6667 | 3 | 9 |
| Mitogen-activated protein kinase kinase kinase kinase 4 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Mitogen-activated protein kinase kinase kinase kinase 5 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Mitotic checkpoint serine/threonine-protein kinase BUB1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| mu-type opioid receptor isoform MOR-1 | Homo sapiens (human) | EC50 | 92.5900 | 1 | 1 |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | EC50 | 1.7000 | 1 | 1 |
| Multifunctional protein ADE2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Muscle, skeletal receptor tyrosine-protein kinase | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Myosin light chain kinase 2, skeletal/cardiac muscle | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Myosin light chain kinase 3 | Homo sapiens (human) | Kd | 21.4286 | 2 | 7 |
| Myosin light chain kinase family member 4 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Myosin light chain kinase, smooth muscle | Gallus gallus (chicken) | Kd | 10.0000 | 1 | 2 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Myosin-10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Myosin-14 | Homo sapiens (human) | Kd | 30.0000 | 1 | 5 |
| Myosin-IIIa | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Myosin-IIIb | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Myotonin-protein kinase | Homo sapiens (human) | Kd | 4.5000 | 2 | 5 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Non-receptor tyrosine-protein kinase TNK1 | Homo sapiens (human) | Kd | 9.3705 | 4 | 10 |
| Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | EC50 | 0.4467 | 3 | 3 |
| Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | Kd | 9.6556 | 6 | 14 |
| NT-3 growth factor receptor | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| NUAK family SNF1-like kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| NUAK family SNF1-like kinase 2 | Homo sapiens (human) | Kd | 13.3880 | 4 | 10 |
| Nuclear receptor subfamily 4 group A member 2 | Homo sapiens (human) | EC50 | 48.5000 | 2 | 2 |
| Nucleolar GTP-binding protein 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Nucleoside diphosphate kinase B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Obg-like ATPase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| PAS domain-containing serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Peptidyl-prolyl cis-trans isomerase A | Homo sapiens (human) | Kd | 0.6225 | 11 | 11 |
| Peptidyl-prolyl cis-trans isomerase B | Homo sapiens (human) | Kd | 0.0098 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase D | Homo sapiens (human) | Kd | 0.0215 | 2 | 2 |
| Peripheral plasma membrane protein CASK | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Peroxisomal acyl-coenzyme A oxidase 1 | Homo sapiens (human) | Kd | 20.0047 | 1 | 3 |
| Peroxisomal acyl-coenzyme A oxidase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Phenylalanine--tRNA ligase beta subunit | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Phosphatidylethanolamine-binding protein 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Phosphatidylinositol 4-kinase beta | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma | Homo sapiens (human) | Kd | 7.5333 | 1 | 3 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | Kd | 10.0000 | 12 | 34 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | Homo sapiens (human) | Kd | 16.2450 | 2 | 7 |
| Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Homo sapiens (human) | Kd | 17.0727 | 4 | 11 |
| Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Homo sapiens (human) | Kd | 6.8800 | 2 | 5 |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | Kd | 7.1850 | 2 | 5 |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | Kd | 14.9724 | 3 | 9 |
| Probable ATP-dependent RNA helicase DDX6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 5 |
| Procathepsin L | Homo sapiens (human) | EC50 | 5.4411 | 1 | 9 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Protein kinase C alpha type | Homo sapiens (human) | Kd | 24.0338 | 1 | 5 |
| Protein kinase C beta type | Homo sapiens (human) | Kd | 29.0810 | 1 | 4 |
| Protein kinase C delta type | Homo sapiens (human) | Kd | 7.2281 | 3 | 9 |
| Protein kinase C epsilon type | Homo sapiens (human) | Kd | 6.1520 | 2 | 5 |
| Protein kinase C eta type | Homo sapiens (human) | Kd | 6.1400 | 2 | 5 |
| Protein kinase C iota type | Homo sapiens (human) | Kd | 21.4286 | 2 | 7 |
| Protein kinase C theta type | Homo sapiens (human) | Kd | 16.7444 | 3 | 9 |
| Protein kinase C zeta type | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Protein-tyrosine kinase 2-beta | Homo sapiens (human) | Kd | 18.1222 | 3 | 9 |
| Protein-tyrosine kinase 6 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | Kd | 12.2136 | 7 | 20 |
| Proto-oncogene tyrosine-protein kinase ROS | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | Kd | 17.8778 | 3 | 9 |
| Putative heat shock protein HSP 90-beta 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Pyridoxal kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 5 |
| Rab-like protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Rac1 protein | Homo sapiens (human) | EC50 | 30.0000 | 2 | 2 |
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| ras protein, partial | Homo sapiens (human) | EC50 | 30.0000 | 2 | 2 |
| Ras-related protein Rab-10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 6 |
| Ras-related protein Rab-27A | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Ras-related protein Rab-2A | Canis lupus familiaris (dog) | EC50 | 30.0000 | 1 | 1 |
| Ras-related protein Rab-6A | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | Kd | 8.2400 | 2 | 5 |
| Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (human) | Kd | 9.7333 | 1 | 3 |
| Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | Kd | 8.3333 | 1 | 3 |
| Receptor-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Receptor-interacting serine/threonine-protein kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Receptor-interacting serine/threonine-protein kinase 4 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | Kd | 11.6278 | 13 | 36 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | EC50 | 5.4411 | 1 | 9 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | Kd | 220.0000 | 1 | 1 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | EC50 | 5.4411 | 1 | 9 |
| Replicase polyprotein 1ab | Human coronavirus 229E | EC50 | 5.4411 | 1 | 9 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | EC50 | 5.4411 | 1 | 9 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | EC50 | 5.4411 | 1 | 9 |
| Rho-associated protein kinase 1 | Homo sapiens (human) | Kd | 10.6974 | 2 | 7 |
| Rho-associated protein kinase 2 | Homo sapiens (human) | Kd | 10.8076 | 2 | 7 |
| Rhodopsin kinase GRK1 | Homo sapiens (human) | Kd | 6.8833 | 1 | 3 |
| Rhodopsin kinase GRK7 | Homo sapiens (human) | Kd | 5.0933 | 1 | 3 |
| Riboflavin-binding protein | Gallus gallus (chicken) | Kd | 2.1000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | Kd | 10.6985 | 5 | 14 |
| Ribosomal protein S6 kinase alpha-2 | Homo sapiens (human) | Kd | 5.1917 | 6 | 12 |
| Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | Kd | 16.1300 | 4 | 10 |
| Ribosomal protein S6 kinase alpha-4 | Homo sapiens (human) | Kd | 13.5167 | 6 | 15 |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | Kd | 14.8000 | 6 | 15 |
| Ribosomal protein S6 kinase alpha-6 | Homo sapiens (human) | Kd | 11.7760 | 6 | 15 |
| Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | Kd | 18.9500 | 2 | 6 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | Kd | 22.6172 | 1 | 4 |
| RNA cytidine acetyltransferase | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| S-adenosylmethionine synthase isoform type-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 5 |
| Septin-9 | Homo sapiens (human) | Kd | 22.5210 | 1 | 4 |
| Serine/threonine-protein kinase 10 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase 16 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase 17A | Homo sapiens (human) | Kd | 8.8200 | 2 | 5 |
| Serine/threonine-protein kinase 17B | Homo sapiens (human) | Kd | 6.4833 | 3 | 6 |
| Serine/threonine-protein kinase 24 | Homo sapiens (human) | Kd | 17.5000 | 3 | 8 |
| Serine/threonine-protein kinase 25 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase 26 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase 3 | Homo sapiens (human) | Kd | 16.7400 | 4 | 10 |
| Serine/threonine-protein kinase 32A | Homo sapiens (human) | Kd | 8.5000 | 1 | 3 |
| Serine/threonine-protein kinase 32B | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase 32C | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase 33 | Homo sapiens (human) | Kd | 6.6800 | 2 | 5 |
| Serine/threonine-protein kinase 35 | Homo sapiens (human) | Kd | 6.8167 | 1 | 3 |
| Serine/threonine-protein kinase 36 | Homo sapiens (human) | Kd | 8.5000 | 3 | 6 |
| Serine/threonine-protein kinase 38 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Serine/threonine-protein kinase 38-like | Homo sapiens (human) | Kd | 15.7143 | 3 | 7 |
| Serine/threonine-protein kinase 4 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase A-Raf | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Serine/threonine-protein kinase ATR | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | Kd | 15.1286 | 5 | 14 |
| Serine/threonine-protein kinase BRSK1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase BRSK2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase Chk2 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Serine/threonine-protein kinase D1 | Homo sapiens (human) | Kd | 6.2080 | 2 | 5 |
| Serine/threonine-protein kinase D2 | Homo sapiens (human) | Kd | 13.7240 | 3 | 9 |
| Serine/threonine-protein kinase D3 | Homo sapiens (human) | Kd | 13.4663 | 3 | 9 |
| Serine/threonine-protein kinase DCLK1 | Homo sapiens (human) | Kd | 6.1800 | 2 | 5 |
| Serine/threonine-protein kinase DCLK2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase DCLK3 | Homo sapiens (human) | Kd | 2.0368 | 3 | 6 |
| Serine/threonine-protein kinase ICK | Homo sapiens (human) | Kd | 21.2501 | 2 | 8 |
| Serine/threonine-protein kinase LATS1 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase LATS2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase MAK | Homo sapiens (human) | Kd | 6.6760 | 1 | 3 |
| Serine/threonine-protein kinase MARK1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase MARK2 | Homo sapiens (human) | Kd | 12.9723 | 3 | 9 |
| Serine/threonine-protein kinase MRCK alpha | Homo sapiens (human) | Kd | 17.0022 | 3 | 9 |
| Serine/threonine-protein kinase MRCK beta | Homo sapiens (human) | Kd | 20.6605 | 3 | 10 |
| Serine/threonine-protein kinase MRCK gamma | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Serine/threonine-protein kinase N1 | Homo sapiens (human) | Kd | 5.7330 | 4 | 10 |
| Serine/threonine-protein kinase N2 | Homo sapiens (human) | Kd | 14.6077 | 3 | 9 |
| Serine/threonine-protein kinase N3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Nek1 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase Nek11 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Serine/threonine-protein kinase Nek2 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase Nek3 | Homo sapiens (human) | Kd | 22.5000 | 2 | 8 |
| Serine/threonine-protein kinase Nek4 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Serine/threonine-protein kinase Nek5 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase Nek6 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase Nek7 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase Nek9 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase NIM1 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Serine/threonine-protein kinase NLK | Homo sapiens (human) | Kd | 15.4855 | 5 | 11 |
| Serine/threonine-protein kinase OSR1 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Serine/threonine-protein kinase PAK 1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase PAK 2 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase PAK 3 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase PAK 4 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase PAK 5 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase PAK 6 | Homo sapiens (human) | Kd | 17.5000 | 3 | 8 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | Kd | 14.2940 | 4 | 10 |
| Serine/threonine-protein kinase pim-2 | Homo sapiens (human) | Kd | 8.8843 | 4 | 7 |
| Serine/threonine-protein kinase pim-3 | Homo sapiens (human) | Kd | 4.3840 | 2 | 5 |
| Serine/threonine-protein kinase PknB | Mycobacterium tuberculosis H37Rv | Kd | 7.3333 | 1 | 3 |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Kd | 13.3333 | 3 | 6 |
| Serine/threonine-protein kinase PLK2 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Serine/threonine-protein kinase PLK3 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | Kd | 18.3182 | 4 | 11 |
| Serine/threonine-protein kinase PRP4 homolog | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Serine/threonine-protein kinase receptor R3 | Homo sapiens (human) | Kd | 12.4167 | 3 | 6 |
| Serine/threonine-protein kinase RIO1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase RIO2 | Homo sapiens (human) | Kd | 7.2333 | 1 | 3 |
| Serine/threonine-protein kinase RIO3 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase SBK1 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Serine/threonine-protein kinase Sgk3 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Serine/threonine-protein kinase SIK1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase SIK2 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase SIK3 | Homo sapiens (human) | Kd | 21.4286 | 2 | 7 |
| Serine/threonine-protein kinase STK11 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Serine/threonine-protein kinase TAO1 | Homo sapiens (human) | Kd | 17.9244 | 2 | 8 |
| Serine/threonine-protein kinase TAO2 | Homo sapiens (human) | Kd | 20.0357 | 2 | 7 |
| Serine/threonine-protein kinase TAO3 | Homo sapiens (human) | Kd | 16.3441 | 2 | 7 |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | Kd | 16.0599 | 2 | 7 |
| Serine/threonine-protein kinase TNNI3K | Homo sapiens (human) | Kd | 6.0220 | 2 | 5 |
| Serine/threonine-protein kinase tousled-like 1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase tousled-like 2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Serine/threonine-protein kinase ULK1 | Homo sapiens (human) | Kd | 20.0900 | 2 | 9 |
| Serine/threonine-protein kinase ULK2 | Homo sapiens (human) | Kd | 6.8233 | 1 | 3 |
| Serine/threonine-protein kinase ULK3 | Homo sapiens (human) | Kd | 20.9143 | 2 | 7 |
| Serine/threonine-protein kinase VRK2 | Homo sapiens (human) | Kd | 6.6877 | 1 | 3 |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | Kd | 22.5000 | 2 | 8 |
| Serine/threonine-protein kinase/endoribonuclease IRE2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Signal recognition particle receptor subunit alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| SNF-related serine/threonine-protein kinase | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | EC50 | 30.0000 | 1 | 1 |
| Spike glycoprotein | Betacoronavirus England 1 | EC50 | 5.4411 | 1 | 9 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | EC50 | 5.4411 | 1 | 9 |
| SRSF protein kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| SRSF protein kinase 2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| SRSF protein kinase 3 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| STE20-like serine/threonine-protein kinase | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| STE20-related kinase adapter protein alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| STE20/SPS1-related proline-alanine-rich protein kinase | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Stromelysin-1 | Homo sapiens (human) | Kd | 25,000.0000 | 1 | 1 |
| Structural maintenance of chromosomes protein 1A | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Structural maintenance of chromosomes protein 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Testis-specific serine/threonine-protein kinase 1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| TGF-beta receptor type-1 | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| TGF-beta receptor type-2 | Homo sapiens (human) | Kd | 17.9111 | 3 | 9 |
| Thyroid hormone receptor-associated protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 5 |
| TRAF2 and NCK-interacting protein kinase | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Transient receptor potential cation channel subfamily A member 1 | Homo sapiens (human) | EC50 | 31.1986 | 2 | 3 |
| Transient receptor potential cation channel subfamily M member 6 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Transmembrane protease serine 2 | Homo sapiens (human) | EC50 | 5.4411 | 1 | 9 |
| Transthyretin | Homo sapiens (human) | Kd | 0.4800 | 1 | 1 |
| Tubulin alpha-1A chain | Rattus norvegicus (Norway rat) | Kd | 10.0000 | 1 | 2 |
| Tyrosine--tRNA ligase, cytoplasmic | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | EC50 | 0.0010 | 1 | 1 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | Kd | 7.0034 | 23 | 63 |
| Tyrosine-protein kinase ABL2 | Homo sapiens (human) | Kd | 14.4960 | 3 | 9 |
| Tyrosine-protein kinase Blk | Homo sapiens (human) | Kd | 8.0300 | 2 | 5 |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Tyrosine-protein kinase CSK | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Tyrosine-protein kinase Fer | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Tyrosine-protein kinase Fes/Fps | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Tyrosine-protein kinase Fgr | Homo sapiens (human) | Kd | 11.7733 | 3 | 6 |
| Tyrosine-protein kinase FRK | Homo sapiens (human) | Kd | 15.1930 | 3 | 10 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | Kd | 16.8044 | 3 | 9 |
| Tyrosine-protein kinase HCK | Homo sapiens (human) | Kd | 19.0690 | 3 | 10 |
| Tyrosine-protein kinase ITK/TSK | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | EC50 | 0.0683 | 6 | 6 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | Kd | 14.2860 | 6 | 14 |
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | EC50 | 0.1266 | 5 | 5 |
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | Kd | 9.5014 | 5 | 9 |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | EC50 | 0.0165 | 2 | 2 |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | Kd | 3.0865 | 4 | 7 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | Kd | 15.8101 | 3 | 9 |
| Tyrosine-protein kinase Lyn | Homo sapiens (human) | Kd | 17.7846 | 3 | 9 |
| Tyrosine-protein kinase Mer | Homo sapiens (human) | Kd | 8.7200 | 2 | 5 |
| Tyrosine-protein kinase receptor Tie-1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Tyrosine-protein kinase receptor TYRO3 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Tyrosine-protein kinase receptor UFO | Homo sapiens (human) | Kd | 7.4000 | 2 | 5 |
| Tyrosine-protein kinase Srms | Homo sapiens (human) | Kd | 6.5600 | 2 | 5 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | Kd | 18.8889 | 3 | 9 |
| Tyrosine-protein kinase Tec | Homo sapiens (human) | Kd | 20.0000 | 3 | 10 |
| Tyrosine-protein kinase TXK | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | Kd | 19.0570 | 3 | 10 |
| Tyrosine-protein kinase ZAP-70 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| U5 small nuclear ribonucleoprotein 200 kDa helicase | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| UMP-CMP kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Uncharacterized aarF domain-containing protein kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Uncharacterized protein FLJ45252 | Homo sapiens (human) | Kd | 22.5195 | 1 | 4 |
| Uncharacterized serine/threonine-protein kinase SBK3 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | Kd | 10.0000 | 2 | 5 |
| Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Wee1-like protein kinase | Homo sapiens (human) | Kd | 20.0000 | 3 | 10 |
| Wee1-like protein kinase 2 | Homo sapiens (human) | Kd | 10.0000 | 1 | 3 |